Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.735 USD | +0.95% | -3.86% | +22.62% |
05-14 | Atea Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-14 | Transcript : Atea Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.62% | 312M | |
+8.70% | 114B | |
+10.86% | 104B | |
-12.80% | 22.41B | |
-1.11% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.97% | 17.89B | |
+7.81% | 14.28B | |
+36.43% | 12.55B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals : JPMorgan Starts Atea Pharmaceuticals at Overweight With $45 Price Target